Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

about

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy

Item

http://www.wikidata.org/entity/Q57484929

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@en

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@nl

type

Item

label

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@en

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@nl

prefLabel

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@en

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@nl

P1476

Locoregional recurrence-associ ...... after neoadjuvant chemotherapy

@en

P2093

Daquan Wang

http://www.w3.org/2001/XMLSchema#string

Jinlin Zhao

http://www.w3.org/2001/XMLSchema#string

Kunpeng Xu

http://www.w3.org/2001/XMLSchema#string

Liming Xu

http://www.w3.org/2001/XMLSchema#string

Lujun Zhao

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Qi Wang

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

Zhenzhen Yin

http://www.w3.org/2001/XMLSchema#string

Zhiyong Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.

Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.

Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

Role of postmastectomy radiation after neoadjuvant chemotherapy in stage II-III breast cancer.

Surgical treatment of primary breast cancer in the neoadjuvant setting.

Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.

P304

4105-4112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S173628

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323666

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

chemotherapy

P932

6174313

http://www.w3.org/2001/XMLSchema#string